2012 results about "First pass" patented technology

An anchor is provided for placement in or against tissue. The anchor includes a fibrous construct and at least a first filament. Each filament passes through the construct in at least three passing locations including a first location nearest a first end of the construct, a last location nearest a second end of said construct, and at least one intermediate location between said first passing location and said last passing location. In an undeployed state, each filament extends a first length between said first location and said last location. In a deployed state, each filament extends a second length between the first location and the last location. The second length is shorter than said first length.

In accordance with an embodiment of the present invention, a static random access memory (SRAM) cell comprises a first pull-down transistor, a first pull-up transistor, a first pass-gate transistor, a second pull-down transistor, a second pull-up transistor, a second pass-gate transistor, a first linear intra-cell connection, and a second linear intra-cell connection. Active areas of the transistors are disposed in a substrate, and longitudinal axes of the active areas of the transistors are all parallel. The first linear intra-cell connection electrically couples the active area of the first pull-down transistor, the active area of the first pull-up transistor, and the active area of the first pass-gate transistor to a gate electrode of the second pull-down transistor and a gate electrode of the second pull-up transistor. The second linear intra-cell connection electrically couples the active area of the second pull-down transistor, the active area of the second pull-up transistor, and the active area of the second pass-gate transistor to a gate electrode of the first pull-down transistor and a gate electrode of the first pull-up transistor.

A multiple pass speech recognition method includes a first pass and a second pass. The first pass recognizes an input speech signal to generate a first pass result. The second pass generates a first grammar having a portion set to match a first part of the input speech signal, based upon the context of the first pass result, and generate a second pass result. The method may further include a third pass grammar limiting the second part of the input speech signal to the second pass result. The third pass grammar includes a model corresponding to the first part of the input speech signal and varying within the second pass result. The third pass compares the first part of the input speech signal to the model while limiting the second part of the input speech signal to the second pass result.

A cardiovascular imaging and functional analysis system and method is disclosed, wherein a dedicated fast, sensitive, compact and economical imaging gamma camera system that is especially suited for heart imaging and functional analysis is employed. The cardiovascular imaging and functional analysis system of the present invention can be used as a dedicated nuclear cardiology small field of view imaging camera. The disclosed cardiovascular imaging system and method has the advantages of being able to image physiology, while offering an inexpensive and portable hardware, unlike MRI, CT, and echocardiography systems.The cardiovascular imaging system of the invention employs a basic modular design suitable for cardiac imaging with one of several radionucleide tracers. The detector can be positioned in close proximity to the chest and heart from several different projections, making it possible rapidly to accumulate data for first-pass analysis, positron imaging, quantitative stress perfusion, and multi-gated equilibrium pooled blood (MUGA) tests..In a preferred embodiment, the Cardiovascular Non-Invasive Screening Probe system can perform a novel diagnostic screening test for potential victims of coronary artery disease. The system provides a rapid, inexpensive preliminary indication of coronary occlusive disease by measuring the activity of emitted particles from an injected bolus of radioactive tracer. Ratios of this activity with the time progression of the injected bolus of radioactive tracer are used to perform diagnosis of the coronary patency (artery disease).